Earnings summaries and quarterly performance for CENTENE.
Executive leadership at CENTENE.
Sarah London
Chief Executive Officer
Andrew Asher
Chief Financial Officer
Christopher Koster
Secretary and General Counsel
Kate Casso
Corporate Controller & Chief Accounting Officer
Susan Smith
Chief Operating Officer
Tanya McNally
Chief People Officer
Board of directors at CENTENE.
Research analysts who have asked questions during CENTENE earnings calls.
Andrew Mok
Barclays
7 questions for CNC
Justin Lake
Wolfe Research, LLC
7 questions for CNC
Lance Wilkes
Sanford C. Bernstein & Co., LLC
7 questions for CNC
Ann Hynes
Mizuho Financial Group
5 questions for CNC
George Hill
Deutsche Bank
5 questions for CNC
Joshua Raskin
Nephron Research
5 questions for CNC
Sarah James
Cantor Fitzgerald
5 questions for CNC
Stephen Baxter
Wells Fargo & Company
5 questions for CNC
A.J. Rice
UBS Group AG
4 questions for CNC
John Stansel
JPMorgan Chase & Co.
4 questions for CNC
Kevin Fischbeck
Bank of America
4 questions for CNC
Albert Rice
UBS
3 questions for CNC
David Windley
Jefferies Financial Group Inc.
3 questions for CNC
Hua Ha
Robert W. Baird & Co. Incorporated
3 questions for CNC
Adam Ron
Bank of America Corporation
2 questions for CNC
Dave Windley
Jefferies LLC
2 questions for CNC
Erin Wright
Morgan Stanley
2 questions for CNC
Josh Raskin
Nathron Research
2 questions for CNC
Michael Ha
Robert W. Baird & Co.
2 questions for CNC
Scott Fidel
Stephens Inc.
2 questions for CNC
Stephen Baxter
Wells Fargo
2 questions for CNC
Christian Bomer
TD Cowen
1 question for CNC
Joaquin Arriagada Martinez
Bank of America
1 question for CNC
Ryan Langston
TD Cowen
1 question for CNC
Recent press releases and 8-K filings for CNC.
- In 2026, Wellcare will offer Medicare Advantage to over 51 million beneficiaries in 32 states (covering >75% of eligible beneficiaries) and Prescription Drug Plans to over 8 million members nationwide, adding 51 new counties across eight states.
- Transitioning five Medicare-Medicaid Plans (MMPs) to integrated Dual Eligible Special Needs Plans (D-SNPs) effective Jan 1, 2026, expanding its integrated D-SNP footprint.
- Enhanced member benefits include the Wellcare Spendables® card accepted at >66,000 retailers, digital mental health support, $0/low PCP copays, and insulin capped at $35 or 25% of the drug price.
- Prescription Drug Plans will feature two products (Classic and Value Script) in all 34 regions with 68 plans nationwide and $0 Tier 1 copays at preferred pharmacies.
- Medicare Advantage to 51 million beneficiaries across 32 states and PDP to over 8 million members nationwide, adding 51 new counties in eight states for the 2026 Annual Enrollment Period (Oct. 15–Dec. 7, 2025).
- Transition of five Medicare-Medicaid Plans to integrated Dual Eligible Special Needs Plans (D-SNPs) in eight states, effective Jan. 1, 2026, to improve care coordination for dual eligibles.
- Enhanced member experience via the Wellcare Spendables® card at 66,000+ retailers, integrated rewards, and modernized onboarding with videos in eight languages.
- Nationwide PDP expansion with 68 Prescription Drug Plans (Classic and Value Script) in all 34 regions, featuring competitive premiums, $0 Tier 1 copays, and $0 cost-sharing for ACIP-recommended vaccines.
- The 2026 Medicare Annual Enrollment Period runs from Oct. 15–Dec. 7, 2025 for coverage effective Jan. 1, 2026.
- Wellcare Medicare Advantage plans will be available to more than 51 million beneficiaries (over 75% of eligible) across 32 states, with footprint expanded by 51 counties in eight states.
- Plan benefits include $0 or low copays for primary care visits, insulin cost capped at $35 or 25% of the negotiated price, $0 cost-sharing for ACIP-recommended Part D vaccines, and a network of over 60,000 pharmacies.
- Medicare Prescription Drug Plans offer two products (Classic and Value Script) in all 34 regions (68 PDPs), featuring $0 Tier 1 copay and competitive low-premium options.
- Reported Q3 results above the July forecast and raised full-year adjusted EPS guidance to at least $2, with October results tracking in line with that outlook.
- Lost the sole-source CMS Florida Medicaid contract, impacting $5 billion of revenue in 2025 and $4.5 billion in 2026; the contract’s low single-digit pre-tax margins led Centene to forgo protesting, focusing instead on a seamless member transition.
- Extended its PBM partnership with Express Scripts through 2030 under a 100% pass-through, 100% transparency model, while retaining flexibility to explore rebate-free options for low-net-cost solutions.
- Early Marketplace open enrollment generated elevated call volumes amid premium-change confusion; Centene projects 15–35% market contraction without enhanced subsidies and is leveraging brokers for member outreach.
- Expects to exit Q4 with a Medicaid Health Benefits Ratio of 93.0%, guiding to consistent 2026 profitability around a full-year HBR of 93.7%, noting ~20% of Medicaid medical spend is behavioral health.
- Wellcare will offer Medicare Advantage to over 51 million beneficiaries in 32 states and Prescription Drug Plans to over 8 million members across all 50 states for 2026.
- Wellcare will transition Medicare-Medicaid Plans (MMPs) to integrated Dual Eligible Special Needs Plans (D-SNPs) in five demonstration states and launch the first phase of its enhanced Duals model in eight states effective Jan. 1, 2026.
- Plan enhancements include the Wellcare Spendables® card, $0 or low copays for primary care visits, Dario digital mental health support, and insulin costs capped at $35 or 25%, whichever is lower.
- PDP offerings will encompass 68 plans (Classic and Value Script) across all 34 regions, featuring $0 copay on Tier 1 generics and competitive formulary designs.
- Wellcare, Centene’s Medicare brand, will offer Medicare Advantage and Prescription Drug Plans in 205 Texas counties for the 2026 Annual Enrollment Period (Oct. 15–Dec. 7), with coverage starting Jan. 1, 2026.
- The company will transition from Medicare-Medicaid Plans (MMPs) to integrated Dual Eligible Special Needs Plans (D-SNPs), launching Phase 1 of its enhanced dual model in Dallas and Hidalgo Counties effective Jan. 1, 2026.
- For 2026, Wellcare plans to serve 51 million+ beneficiaries across 32 states and 1,850+ counties, adding 51 new counties including several in Texas.
- Key 2026 benefits include $0 or low copays for primary care, insulin costs capped at $35 or 25%, $0 cost-sharing for adult Part D vaccinations, and access to a 60,000+ pharmacy network with Express Scripts® home delivery.
- Centene’s Wellcare Medicare Advantage plans will be available in 32 states, serving over 51 million beneficiaries across more than 1,850 counties, including launches in 13 California counties for 2026 enrollment.
- The company is enhancing its Dual Eligible Special Needs Plans (D-SNPs) integration and upgrading the Wellcare Spendables® card, alongside new digital onboarding and member engagement tools.
- 2026 Medicare Advantage benefits include $0 or low copays for primary care visits, capped insulin costs at $35 or 25%, $0 cost-sharing for ACIP-recommended Part D vaccines, and a $2,100 annual out-of-pocket cap.
- Wellcare’s Prescription Drug Plans will offer 68 PDPs (Classic and Value Script) in all 34 regions, featuring $0 copay on Tier 1 prescriptions at preferred pharmacies.
- Wellcare will offer Medicare Advantage to over 51 million beneficiaries in 32 states and Prescription Drug Plans to more than 8 million members nationwide in 2026.
- The company will transition Medicare-Medicaid Plan demonstrations to integrated Dual Eligible Special Needs Plans (D-SNPs) in five states and has added 51 new counties across eight markets.
- Medicare Advantage enhancements include the Wellcare Spendables® card, $0 or low primary care copays, an insulin cost cap of $35, $0 cost-sharing for ACIP-recommended vaccinations, and 24/7 digital mental health support via Dario.
- Prescription Drug Plan offerings consist of two products (Classic and Value Script) across 34 regions with 68 plans nationwide, featuring low premiums and $0 Tier 1 copays at preferred pharmacies.
- During the Health Insurance Marketplace open enrollment (Nov. 1, 2025 – Jan. 15, 2026), Ambetter from Superior HealthPlan and Ambetter Health will be available in 150 Texas counties for plan year 2026.
- Plans cover all essential health benefits, with some including dental and vision, plus condition-specific diabetes options offering $0 copays on preferred medications and supplies.
- Ambetter Health Solutions delivers off-exchange, ICHRA-compatible individual plans, supporting employers’ cost control and employee choice.
- Members can earn up to $500 through the My Health Pays wellness program and access 24/7 virtual care, digital enrollment tools, a mobile app and Wellframe support.
- Centene’s Ambetter Health will offer health insurance plans in 63 Florida counties for plan year 2026, expanding access for under-insured populations via the Health Insurance Marketplace.
- The open enrollment period runs from Nov. 1, 2025, through Jan. 15, 2026 (enroll by Dec. 15, 2025 for Jan. 1, 2026 coverage).
- Plans cover all essential health benefits—including maternity, mental health, hospitalizations, and prescription drugs—and optional dental/vision, supported by the My Health Pays program with up to $500 in rewards.
- New offerings include ICHRA-compatible off-exchange plans through Ambetter Health Solutions and 24/7 virtual telehealth services for members.
Quarterly earnings call transcripts for CENTENE.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more